Also trades as: PRN.TO (TSX) · $vol 0M
PROF NASDAQ
Profound Medical Corp.
1W: +1.4%
1M: -14.4%
3M: -20.8%
YTD: -23.8%
1Y: +18.2%
3Y: -39.2%
5Y: -61.0%
$5.84
-0.01 (-0.17%)
Weekly Expected Move ±7.9%
$5
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$16M
+58.3% ▲
5Y CAGR: +17.1%
Gross Profit
$11M
+70.1% ▲
5Y CAGR: +26.8%
Operating Income
-$41M
-31.1% ▼
Net Income
$42M
+259.8% ▲
EPS (Diluted)
$1.41
+231.8% ▲
EBITDA
-$57M
-122.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7M | $7M | $7M | $10M | $16M |
| YoY Growth | -5.9% | -2.8% | +7.8% | +41.2% | +58.3% |
| Cost of Revenue | $4M | $4M | $3M | $3M | $5M |
| Gross Profit | $3M | $3M | $4M | $7M | $11M |
| Gross Margin | 43.0% | 45.2% | 60.9% | 65.9% | 70.8% |
| R&D Expenses | $15M | $15M | $14M | $16M | $21M |
| SG&A Expenses | $18M | $18M | $19M | $22M | $32M |
| Operating Expenses | $33M | $35M | $33M | $38M | $53M |
| Operating Income | -$30M | -$32M | -$29M | -$31M | -$41M |
| Operating Margin | -440.7% | -480.9% | -397.5% | -309.6% | -256.3% |
| Interest Expense | $66K | $167K | $770K | $0 | $0 |
| Income Before Tax | -$31M | -$28M | -$29M | -$26M | $42M |
| Tax Expense | $105K | $287K | -$128K | -$2K | $252K |
| Net Income | -$31M | -$29M | -$29M | -$26M | $42M |
| Net Margin | -446.7% | -429.1% | -396.8% | -260.4% | 262.9% |
| EPS (Diluted) | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $1.41 |
| EBITDA | -$29M | -$27M | -$27M | -$26M | -$57M |
| Shares Outstanding | 20M | 21M | 21M | 25M | 30M |